MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 20 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,762,000 | $22,928,000 | 0.34% |
| WOLVERINE ASSET MANAGEMENT LLC | 9,998,000 | $8,555,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,331,000 | $1,138,000 | 0.04% |
| PUTNAM INVESTMENTS LLC | 2,876,000 | $2,459,000 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 3,300,000 | $2,838,000 | 0.01% |
| AMERIPRISE FINANCIAL INC | 3,320,000 | $2,839,000 | 0.00% |
| UBS Group AG | 1,000 | $1,000 | 0.00% |
| Jefferies Group LLC | 10,000 | $8,000 | 0.00% |
| JPMORGAN CHASE & CO | 2,015,000 | $1,730,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 7,000 | $7,000 | 0.00% |